Centene's Sunflower Health Plan achieved a 4-star rating in the 2026 NCQA Medicaid rankings, marking a year-over-year improvement for the Kansas-based subsidiary.
Centene's wholly owned subsidiary Sunflower Health Plan earned 4 out of 5 stars in NCQA's Medicaid Health Plan Ratings 2026, an increase from the prior year per the release. Higher quality stars can help a Medicaid plan defend or win state contracts, a mild positive for the parent, but no financial figures or contract awards are given.
It earned 4 out of 5 stars in NCQA's Medicaid Health Plan Ratings 2026, an increase from the prior rating.
Sunflower is a wholly owned Centene subsidiary, so a better quality score may support its position in Medicaid programs, but the release cites no financial impact.
Centene Corporation subsidiary Sunflower Health Plan has secured a 4 out of 5 star rating in the NCQA Medicaid Health Plan Ratings for 2026. This improved performance reflects the company's commitment to quality care standards within its Medicaid programs.
The 4-star rating serves as a quality benchmark that can strengthen the plan's competitive position when bidding for or renewing state Medicaid contracts.
While the improved rating is a positive operational indicator for the subsidiary, the company has not disclosed any specific financial impact or changes to earnings guidance.